Stevens Capital Management LP purchased a new position in shares of Cantel Medical Corp. (NYSE:CMD) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 6,154 shares of the company’s stock, valued at approximately $580,000.
A number of other hedge funds have also recently modified their holdings of CMD. Capstone Asset Management Co. bought a new stake in shares of Cantel Medical Corp. in the 2nd quarter valued at about $690,000. Bank of Montreal Can bought a new stake in shares of Cantel Medical Corp. in the 2nd quarter valued at about $248,000. State of Alaska Department of Revenue bought a new stake in shares of Cantel Medical Corp. in the 2nd quarter valued at about $558,000. LS Investment Advisors LLC bought a new stake in shares of Cantel Medical Corp. in the 2nd quarter valued at about $172,000. Finally, Nisa Investment Advisors LLC bought a new stake in shares of Cantel Medical Corp. in the 2nd quarter valued at about $3,094,000. 85.16% of the stock is owned by hedge funds and other institutional investors.
A number of research firms have recently weighed in on CMD. Sidoti raised Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 target price for the company in a research note on Wednesday, August 2nd. Zacks Investment Research raised Cantel Medical Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday, August 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical Corp. in a research note on Friday, September 1st. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $91.67.
COPYRIGHT VIOLATION NOTICE: “Stevens Capital Management LP Purchases Shares of 6,154 Cantel Medical Corp. (CMD)” was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://sportsperspectives.com/2017/11/17/stevens-capital-management-lp-purchases-shares-of-6154-cantel-medical-corp-cmd-4.html.
In related news, EVP Eric W. Nodiff sold 2,868 shares of the business’s stock in a transaction dated Friday, October 20th. The stock was sold at an average price of $97.55, for a total transaction of $279,773.40. Following the transaction, the executive vice president now owns 39,102 shares in the company, valued at approximately $3,814,400.10. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Mark N. Diker sold 7,000 shares of the business’s stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $98.90, for a total value of $692,300.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 36,368 shares of company stock worth $3,576,028. 14.90% of the stock is owned by company insiders.
Shares of Cantel Medical Corp. (NYSE:CMD) opened at $103.99 on Friday. Cantel Medical Corp. has a 52 week low of $69.21 and a 52 week high of $104.18. The company has a quick ratio of 1.49, a current ratio of 2.41 and a debt-to-equity ratio of 0.24. The firm has a market capitalization of $4,209.05, a PE ratio of 48.49 and a beta of 1.23.
Cantel Medical Corp. (NYSE:CMD) last announced its quarterly earnings results on Thursday, September 28th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.02. Cantel Medical Corp. had a return on equity of 17.60% and a net margin of 9.27%. The company had revenue of $205.50 million for the quarter, compared to the consensus estimate of $200.32 million. The business’s quarterly revenue was up 14.8% on a year-over-year basis. analysts expect that Cantel Medical Corp. will post 2.34 earnings per share for the current year.
The firm also recently declared a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be issued a dividend of $0.085 per share. This represents a yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 16th. This is an increase from Cantel Medical Corp.’s previous Semi-Annual dividend of $0.07. Cantel Medical Corp.’s payout ratio is currently 8.19%.
Cantel Medical Corp. Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.